Cotinga Pharmaceuticals Publicly Traded Corporation
Critical Outcome Technologies Inc. (COTI) believes that there must be a better way to get safe and effective new drug therapies to people in need on a more timely, cost effective and efficient manner.
Their business is disease-specific drug discovery, optimization and pre-clinical development using a specially developed series of computer models. COTI is focused on the discovery and pre-clinical development of small molecules for the treatment of serious diseases for which current therapy is either lacking or ineffective.
Founded Date:
1999-01-01
Last Funding Date:
2017-10-06
Headquarters:
London,England,United Kingdom,Europe
Total Funding:
4242020
Funding Stage:
IPO
Funding Total Value:
4242020
Last Funding Total Usd:
1197466
Last Funding Total Currency:
CAD
Last Funding Total Value:
1500000
Founders:
Wayne Danter
Phone Number:
1-800-798-8680
Stock Symbol:
COT
City:
London
Region:
England
Country:
United Kingdom